Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
11 10 2021
Historique:
received: 16 11 2020
accepted: 21 09 2021
entrez: 12 10 2021
pubmed: 13 10 2021
medline: 24 12 2021
Statut: epublish

Résumé

Cytomegalovirus reactivation is still a critical concern following allogeneic hematopoietic cell transplantation, and cellular immune reconstitution of cytomegalovirus-specific cytotoxic T-cells is necessary for the long-term control of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation. Here we show the features of repertoire diversity and the gene expression profile of HLA-A24 cytomegalovirus-specific cytotoxic T-cells in actual recipients according to the cytomegalovirus reactivation pattern. A skewed preference for BV7 genes and sequential "G" amino acids motif is observed in complementarity-determining region-3 of T cell receptor-β. Increased binding scores are observed in T-cell clones with complementarity-determining region-3 of T cell receptor-β with a "(G)GG" motif. Single-cell RNA-sequence analyses demonstrate the homogenous distribution of the gene expression profile in individual cytomegalovirus-specific cytotoxic T-cells within each recipient. On the other hand, bulk RNA-sequence analyses reveal that gene expression profiles among patients are different according to the cytomegalovirus reactivation pattern, and are associated with cytokine production or cell division. These methods and results can help us to better understand immune reconstitution following hematopoietic cell transplantation, leading to future studies on the clinical application of adoptive T-cell therapies.

Identifiants

pubmed: 34635773
doi: 10.1038/s42003-021-02709-7
pii: 10.1038/s42003-021-02709-7
pmc: PMC8505416
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1177

Subventions

Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP17fm0208015
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP20ck0106479h

Informations de copyright

© 2021. The Author(s).

Références

Immunity. 2019 Apr 16;50(4):1007-1023
pubmed: 30995492
J Immunol. 1999 Feb 1;162(3):1223-6
pubmed: 9973372
Nat Med. 2017 Jan 6;23(1):18-27
pubmed: 28060797
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Int J Hematol. 2010 May;91(4):588-95
pubmed: 20414753
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16963-8
pubmed: 12486241
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8856-61
pubmed: 12853576
Biol Blood Marrow Transplant. 2014 Sep;20(9):1307-13
pubmed: 24769317
PLoS One. 2013 Sep 05;8(9):e73754
pubmed: 24040054
Am J Transplant. 2016 Aug;16(8):2254-69
pubmed: 26991039
Clin Infect Dis. 2012 Oct;55(8):1064-73
pubmed: 22806594
Immunol Rev. 2009 Jul;230(1):160-71
pubmed: 19594635
Front Immunol. 2018 Apr 10;9:760
pubmed: 29692783
Front Immunol. 2020 Aug 25;11:1803
pubmed: 32983088
Eur J Immunol. 1999 Jun;29(6):2037-45
pubmed: 10382767
Bioinformatics. 2009 Apr 15;25(8):1091-3
pubmed: 19237447
J Biol Chem. 2003 May 2;278(18):16151-8
pubmed: 12594219
Curr Pharm Des. 2013;19(9):1680-98
pubmed: 23061726
Front Immunol. 2017 Jun 14;8:692
pubmed: 28659925
Haematologica. 1999 Jan;84(1):71-9
pubmed: 10091394
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Clin Infect Dis. 2019 Apr 8;68(8):1420-1426
pubmed: 30137245
Immune Netw. 2019 Aug 16;19(4):e25
pubmed: 31501713
Nature. 2008 Dec 18;456(7224):989-92
pubmed: 19011614
Curr Opin Immunol. 2013 Oct;25(5):646-52
pubmed: 24140071
Cancer Immunol Immunother. 2020 May;69(5):789-797
pubmed: 32055919
Clin Infect Dis. 2009 Dec 15;49(12):1851-60
pubmed: 19911966
Bone Marrow Transplant. 2014 Jan;49(1):87-94
pubmed: 23933763
Blood. 2010 Nov 18;116(20):4360-7
pubmed: 20625005
Bioinformatics. 2013 Mar 1;29(5):661-3
pubmed: 23325622
Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69
pubmed: 21236396
Nature. 2018 Jun;558(7711):610-614
pubmed: 29925952
Nucleic Acids Res. 2020 Jan 8;48(D1):D1057-D1062
pubmed: 31588507
J Exp Med. 2005 Aug 1;202(3):379-86
pubmed: 16061727
Nucleic Acids Res. 2018 Jan 4;46(D1):D419-D427
pubmed: 28977646
J Immunol. 2003 Mar 15;170(6):3233-42
pubmed: 12626582
mBio. 2020 Mar 17;11(2):
pubmed: 32184241
FEBS Lett. 1998 Jul 24;431(3):351-6
pubmed: 9714541
Genes Dev. 2016 Dec 15;30(24):2696-2709
pubmed: 28087714
Leukemia. 2020 May;34(5):1422-1432
pubmed: 31772297
Transplant Proc. 1996 Jun;28(3):1750-3
pubmed: 8658867
Leukemia. 2017 Oct;31(10):2161-2171
pubmed: 28090089
Sci Rep. 2018 Mar 22;8(1):5017
pubmed: 29567951
Clin Infect Dis. 1992 Apr;14(4):831-5
pubmed: 1315585
J Antimicrob Chemother. 2006 May;57(5):1004-7
pubmed: 16551692
Transpl Infect Dis. 2014 Dec;16(6):930-40
pubmed: 25430567
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4772-7
pubmed: 10781083
Clin Infect Dis. 2011 Jan 1;52(1):49-57
pubmed: 21148519
J Biol Chem. 2018 Jan 12;293(2):484-496
pubmed: 29162720
Transplantation. 2002 Feb 27;73(4):568-72
pubmed: 11889432
J Biol Chem. 2000 Feb 18;275(7):4670-8
pubmed: 10671496
Blood. 2003 Dec 15;102(13):4255-60
pubmed: 12933590
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Int Immunol. 2000 Feb;12(2):151-60
pubmed: 10653850
Med Microbiol Immunol. 2019 Aug;208(3-4):365-373
pubmed: 30989333
Nat Med. 2013 Mar;19(3):372-7
pubmed: 23435170
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Mol Cancer Ther. 2021 Jun;20(6):961-974
pubmed: 33850005
J Virol. 2017 Sep 12;91(19):
pubmed: 28724766
Blood. 2013 Jun 13;121(24):4955-62
pubmed: 23652802
J Clin Immunol. 2012 Dec;32(6):1340-52
pubmed: 22763862
J Immunol. 2006 Jul 1;177(1):36-9
pubmed: 16785495
Nat Immunol. 2019 Dec;20(12):1584-1593
pubmed: 31745336
N Engl J Med. 1995 Oct 19;333(16):1038-44
pubmed: 7675046
Science. 1992 Jul 10;257(5067):238-41
pubmed: 1352912
Sci Rep. 2017 Jun 16;7(1):3663
pubmed: 28623251
Haematologica. 2019 Mar;104(3):622-631
pubmed: 30262565
Brief Bioinform. 2018 Jul 20;19(4):554-565
pubmed: 28077404
PLoS Pathog. 2014 Sep 25;10(9):e1004380
pubmed: 25255144
Sci Rep. 2019 Nov 11;9(1):16499
pubmed: 31712609
Cell Rep. 2017 Apr 18;19(3):569-583
pubmed: 28423320
J Biol Chem. 2002 Nov 29;277(48):46151-8
pubmed: 12359715
Cancer Sci. 2010 Mar;101(3):594-600
pubmed: 20132220
Cancer Res. 2010 Aug 1;70(15):6181-92
pubmed: 20647322

Auteurs

Hideki Nakasone (H)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. nakasone-tky@umin.ac.jp.

Machiko Kusuda (M)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Kiriko Terasako-Saito (K)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Koji Kawamura (K)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Yu Akahoshi (Y)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Masakatsu Kawamura (M)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Junko Takeshita (J)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Shunto Kawamura (S)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Nozomu Yoshino (N)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Kazuki Yoshimura (K)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Yukiko Misaki (Y)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Ayumi Gomyo (A)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Kazuaki Kameda (K)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Masaharu Tamaki (M)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Aki Tanihara (A)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Shun-Ichi Kimura (SI)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Shinichi Kako (S)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

Yoshinobu Kanda (Y)

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. ycanda-tky@umin.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH